ACRS – aclaris therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

ACRS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/19

04:57 pm

acrs

Aclaris Therapeutics files to sell 35.56M shares of common stock by selling shareholders [Seeking Alpha]

Low Report

Aclaris Therapeutics files to sell 35.56M shares of common stock by selling shareholders [Seeking Alpha]

Report

12/3

04:38 pm

acrs

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) [Yahoo! Finance]

Low Report

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) [Yahoo! Finance]

Report

12/3

04:30 pm

acrs

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Neutral Report

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Report

11/26

04:30 pm

acrs

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Medium Report

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Report

11/21

07:24 pm

acrs

Aclaris Therapeutics And 2 Other US Penny Stocks To Watch [Yahoo! Finance]

Medium Report

Aclaris Therapeutics And 2 Other US Penny Stocks To Watch [Yahoo! Finance]

Report

11/20

03:46 pm

acrs

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating.

Low Report

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating.

Report

11/20

06:05 am

acrs

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.

High Report

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.

Report

11/19

03:31 pm

acrs

Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments [Yahoo! Finance]

Medium Report

Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments [Yahoo! Finance]

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/6/2024

07:00 am

acrs

aclaris therapeutics, inc.

MISS Report

7.6%

aclaris therapeutics, inc.

Report

8/7/2024

07:00 am

acrs

aclaris therapeutics, inc.

BEAT Report

-2.5%

aclaris therapeutics, inc.

Report

5/7/2024

04:01 pm

acrs

aclaris therapeutics, inc.

BEAT Report

-9.0%

aclaris therapeutics, inc.

Report

2/27/2024

07:00 am

acrs

aclaris therapeutics, inc.

BEAT Report

-4.0%

aclaris therapeutics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/20

03:46 pm

Upgrades

Neutral

Overweight

Cantor Fitzgerald

Low

Report

1.3%

Report

11/19

08:30 am

Upgrades

Market Perform

Outperform

Leerink Partners

High

Report

24.7%

Report

11/19

08:29 am

Upgrades

Market Perform

Outperform

Leerink Partners

High

Report

28.2%

Report

11/19

08:12 am

Upgrades

Hold

Buy

Jefferies

High

Report

21.1%

Report

11/19

08:12 am

Upgrades

Hold

Buy

Jefferies

High

Report

21.1%

Report

11/19

07:30 am

Upgrades

Neutral

Buy

BTIG Research

High

Report

21.1%

Report

11/19

04:45 am

Upgrades

Neutral

Buy

BTIG

High

Report

35.0%

Report

Date

Time

Symbol

Headline

Impact

12/19

04:32 pm

acrs

Form S-3 Aclaris Therapeutics,

Medium Report

Form S-3 Aclaris Therapeutics,

Report

12/12

04:15 pm

acrs

Form 4 Aclaris Therapeutics, For: Dec 10 Filed by: Monahan Joseph

Low Report

Form 4 Aclaris Therapeutics, For: Dec 10 Filed by: Monahan Joseph

Report

12/6

04:16 pm

acrs

Form 4 Aclaris Therapeutics, For: Dec 04 Filed by: Walker Neal

Low Report

Form 4 Aclaris Therapeutics, For: Dec 04 Filed by: Walker Neal

Report

12/4

08:07 am

acrs

Form D Aclaris Therapeutics,

Medium Report

Form D Aclaris Therapeutics,

Report

12/3

05:43 pm

acrs

Form 4 Aclaris Therapeutics, For: Dec 02 Filed by: Davis Hugh M.

Medium Report

Form 4 Aclaris Therapeutics, For: Dec 02 Filed by: Davis Hugh M.

Report

12/3

04:15 pm

acrs

Form 4 Aclaris Therapeutics, For: Dec 01 Filed by: Walker Neal

Medium Report

Form 4 Aclaris Therapeutics, For: Dec 01 Filed by: Walker Neal

Report

11/27

04:03 pm

acrs

Form S-8 Aclaris Therapeutics,

Medium Report

Form S-8 Aclaris Therapeutics,

Report

11/25

11:03 am

acrs

Form 3 Aclaris Therapeutics, For: Nov 18 Filed by: Biosion, Inc.

Neutral Report

Form 3 Aclaris Therapeutics, For: Nov 18 Filed by: Biosion, Inc.

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.